메뉴 건너뛰기




Volumn 36, Issue 2, 2011, Pages 165-168

Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; ETIDRONIC ACID; GLUCOCORTICOID;

EID: 79951657788     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03856.x     Document Type: Article
Times cited : (8)

References (9)
  • 1
    • 79951596277 scopus 로고    scopus 로고
    • Steroid use in the dermatological field and actual prophylactic treatment for steroid-induced osteoporosis [in Japanese; abstract in English]
    • Furukawa F, Takigawa M, Katayama I. Steroid use in the dermatological field and actual prophylactic treatment for steroid-induced osteoporosis [in Japanese; abstract in English]. Nishinihon Dermatol 2002; 64: 724-45.
    • (2002) Nishinihon Dermatol , vol.64 , pp. 724-45
    • Furukawa, F.1    Takigawa, M.2    Katayama, I.3
  • 2
    • 67649305059 scopus 로고    scopus 로고
    • Actual prophylactic therapy in the dermatological field for steroid-induced osteoporosis following oral therapy (second report) [in Japanese; abstract in English]
    • Furukawa F, Sato S, Takigawa M. Actual prophylactic therapy in the dermatological field for steroid-induced osteoporosis following oral therapy (second report) [in Japanese; abstract in English]. Nishinihon Dermatol 2009; 71: 209-15.
    • (2009) Nishinihon Dermatol , vol.71 , pp. 209-15
    • Furukawa, F.1    Sato, S.2    Takigawa, M.3
  • 3
    • 0030742358 scopus 로고    scopus 로고
    • Preventing glucocorticoid-induced bone loss
    • Reid IR. Preventing glucocorticoid-induced bone loss. N Engl J Med 1997; 337: 420-1.
    • (1997) N Engl J Med , vol.337 , pp. 420-1
    • Reid, I.R.1
  • 4
    • 0036820983 scopus 로고    scopus 로고
    • The epidemiology of glucocorticoid-induced osteoporosis; a meta-analysis
    • van Staa TP, Leufkens HG, Cooper C. The epidemiology of glucocorticoid-induced osteoporosis; a meta-analysis. Osteoporos Int 2002; 13: 777-87.
    • (2002) Osteoporos Int , vol.13 , pp. 777-87
    • van Staa, T.P.1    Leufkens, H.G.2    Cooper, C.3
  • 5
    • 30844435903 scopus 로고    scopus 로고
    • Glucocorticoid-induced bone loss in dermatologic patients
    • Brett T, Summey MD, Gil Yosipovitch MD. Glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol 2006; 142: 82-90.
    • (2006) Arch Dermatol , vol.142 , pp. 82-90
    • Brett, T.1    Summey, M.D.2    Gil Yosipovitch, M.D.3
  • 6
    • 30844467311 scopus 로고    scopus 로고
    • Werth Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy
    • Liu RH, Albrecht J. Werth Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy. Arch Dermatol 2006; 142: 37-41.
    • (2006) Arch Dermatol , vol.142 , pp. 37-41
    • Liu, R.H.1    Albrecht, J.2
  • 7
    • 0035049687 scopus 로고    scopus 로고
    • Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients
    • Yosipovitch G, Hoon TS, Leok GC. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol 2001; 137: 477-81.
    • (2001) Arch Dermatol , vol.137 , pp. 477-81
    • Yosipovitch, G.1    Hoon, T.S.2    Leok, G.C.3
  • 8
    • 0032801272 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study
    • Yoshimura N, Hashimoto T, Sakata K et al. Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study. Calcif Tissue Int 1999; 65: 198-202.
    • (1999) Calcif Tissue Int , vol.65 , pp. 198-202
    • Yoshimura, N.1    Hashimoto, T.2    Sakata, K.3
  • 9
    • 0030752221 scopus 로고    scopus 로고
    • Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
    • Adachi JD, Bensen WG, Brown J et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-7.
    • (1997) N Engl J Med , vol.337 , pp. 382-7
    • Adachi, J.D.1    Bensen, W.G.2    Brown, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.